Turkish Health Enhancement Lifestyle Profile-Screener Questionnaire

The aim of this study was to evaluate the validity, reliability, and cultural adaptation of the Turkish version of the Health Enhancement Lifestyle Profile Screener (T-HELP-Screener).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Elderly Population

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Özgü İnal

Ankara, Merkez, Turkey (Türkiye)

About this study

Internal consistency of the T-HELP-Screener was measured using Kuder-Richardson. Test-retest reliability was performed with 66 of the 150 participants using intraclass correlation coefficient (ICC). Construct validity of the T-HELP-Screener was analyzed with the Healthy Lifestyle Behavior Scale-II (HLBS-II).

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age over 65 years, no communication problems, and a Mini-Mental State Examination score of 24 or above

Exclusion criteria

communication problem

Treatment and study plan

translation and adaptation study

Other

translation and adaptation study

Primary outcomes

Healthy Lifestyle Behavior Scale-II

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Hacettepe University

Other

Registry information

Official study title

Psychometric Properties of The Turkish Health Enhancement Lifestyle Profile-Screener Questionnaire (T-Help-Screener)

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Jul 2, 2021
Registry last updated: Jul 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed